AngioDynamics (ANGO) Tops Q1 Views; Raises FY10 Outlook
AngioDynamics (Nasdaq: ANGO) reports Q1 EPS of $0.09, 1 cent better than the analyst estimate of $0.08. Revenue for the quarter was $50.1 million, which compares to the estimate of $47.79 million.
Raises FY10 sales guidance from $209-$215 million to $211-$215 million, which compares to the Street estimate of $209.92 million. FY10 EPS move to $0.45-$0.47, versus the consensus of $0.45.
Raises FY10 sales guidance from $209-$215 million to $211-$215 million, which compares to the Street estimate of $209.92 million. FY10 EPS move to $0.45-$0.47, versus the consensus of $0.45.
You May Also Be Interested In
- UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower
- Monro Muffler (MNRO) Tops Q4 EPS by 1c; Comps About Flat; Guides FY13 EPS Below Views
- Flowers Foods, Inc. (FLO) Reports In-Line Q1 EPS; Adjusts FY12 EPS Growth Outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Hot ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
